Northstallings9910

phy.BACKGROUND Small bowel vascular malformation disease (SBVM) is the most common cause of obscure gastrointestinal bleeding (OGIB). Several studies suggested that EGFL6 was able to promote the growth of tumor endothelial cells by forming tumor vessels. To date, it remains unclear how EGFL6 promotes pathological angiogenesis in SBVM and whether EGFL6 is a target of thalidomide. METHODS We took advantage of SBVM plasma and tissue samples and compared the expression of EGFL6 between SBVM patients and healthy people via ELISA and Immunohistochemistry. We elucidated the underlying function of EGFL6 in SBVM in vitro and by generating a zebrafish model that overexpresses EGFL6, The cycloheximide (CHX)-chase experiment and CoIP assays were conducted to demonstrate that thalidomide can promote the degradation of EGFL6 by targeting CRBN. RESULTS The analysis of SBVM plasma and tissue samples revealed that EGFL6 was overexpressed in the patients compared to healthy people. Using in vitro and in vivo assays, we demonstrated that an EMT pathway triggered by the EGFL6/PAX6 axis is involved in the pathogenesis of SBVM. Furthermore, through in vitro and in vivo assays, we elucidated that thalidomide can function as anti-angiogenesis medicine through the regulation of EGFL6 in a proteasome-dependent manner. Finally, we found that CRBN can mediate the effect of thalidomide on EGFL6 expression and that the CRBN protein interacts with EGFL6 via a Lon N-terminal peptide. CONCLUSION Our findings revealed a key role for EGFL6 in SBVM pathogenesis and provided a mechanism explaining why thalidomide can cure small bowel bleeding resulting from SBVM.Epithelial to mesenchymal transition (EMT) is a complex plastic and reversible cellular process that has critical roles in diverse physiological and pathological phenomena. EMT is involved in embryonic development, organogenesis and tissue repair, as well as in fibrosis, cancer metastasis and drug resistance. In recent years, the ability to edit the genome using the clustered regularly interspaced palindromic repeats (CRISPR) and associated protein (Cas) system has greatly contributed to identify or validate critical genes in pathway signaling. This review delineates the complex EMT networks and discusses recent studies that have used CRISPR/Cas technology to further advance our understanding of the EMT process.Mitogen-activated protein kinase kinase 9 (MKK9) is an upstream activator of mitogen-activated protein kinase 3 (MAPK3) and MAPK6 in planta. To investigate MKK9 roles in mitochondrial respiration in Arabidopsis, MKK9DD, the active allele with mutations of Thr-201 and Ser-205 to Asp, and MKK9KR, the allele lacking MKK9 activity with a mutation of Lys-76 to Arg, were used. Results showed that the total respiratory rate (Vt), alternative pathway capacity (Valt) and cytochrome pathway capacity (Vcyt) increased under 0-100 mM NaCl treatments but decreased under 150-300 mM NaCl treatments in Col-0 callus. However, the activation of MKK9 by dexamethasone (DEX) increased Vt, Valt and Vcyt under 200 mM NaCl treatment; moreover, Valt showed more increase than Vcyt. The activation of MKK9 in MKK9DD callus sharply increased AOX protein expression under normal and NaCl conditions, but the increase was not observed in MKK9KR callus. Saracatinib clinical trial Further results indicated that MAPK3 and MAPK6 were involved in the MKK9-induced increase of AOX protein levels. qRT-PCR results showed that MKK9-MAPK3/MAPK6 was involved in the NaCl-induced AOX1b and AOX1d expression, but only MKK9-MAPK3 was necessary for AOX2 expression; in addition, MAPK3 regulated the AOX1a transcription in an MKK9-independent manner. MKK9 positively regulated SOD and CAT activities by affecting MAPK3 and MAPK6 and negatively regulated APX and POD activities by affecting MAPK3. Moreover, MKK9 functions as a positive factor in H2O2 accumulation under salt stress. The regulation of ethylene on alternative respiration was also associated with MKK9 under salt stress. Taken together, the MKK9-MAPK3/MAPK6 pathway plays a pivotal role in increasing alternative respiration in the salt-treated Arabidopsis callus.The 5α-reductase converts testosterone to dihydrotestosterone (DHT), and excess DHT could cause androgen-related diseases such as androgenetic alopecia and benign prostatic hyperplasia (BPH). To discover new 5α-reductase inhibitors, effective drug screening method with high throughput is thus essential. In this study, fully automated chip-based nanoelectrospray ionization-mass spectrometry (nano-ESI-MS) was innovatively utilized as a screening tool for 5α-reductase inhibitory assay in direct infusion mode, which simplified sample pretreatment and greatly improved experimental efficiency. The preliminary data indicated that curcumin, a natural anti-inflammatory compound, exhibited notably 5α-reductase inhibition activity. Moreover, the obtained results of the chip-based nano-ESI-MS were well consistent with those of HPLC-MS, which suggested that the chip-based nano-ESI-MS could be treated as a rapid and high-throughput drugs screening strategy in pharmaceutical development. Graphical abstract.As quantitative analysis of biotherapeutics in cerebrospinal fluid (CSF) with LC-MS becomes increasingly widespread, there is a need for method developments towards higher sensitivity. By using artificial CSF (aCSF) in the development phase, the consumption of costly and sparsely available CSF can be limited. The aCSF compositions tested here were made from various dilutions of bovine serum albumin (BSA) or rat plasma to mimic the total protein concentration found in CSF. Focusing on monoclonal antibodies, the aCSF was spiked with human immunoglobulin (hIgG) and prepared with the bottom-up analysis technique using LC-MS. Assuming that the composition of the aCSF would affect the digest, the response from aCSF matrices was compared with CSF from rat, monkey, and dog in terms of estimated sample concentration and matrix effects. The samples were spiked with hIgG in the range of 10 to 1000 ng/mL and volumes of 10 μL were transferred to sample preparation. The results indicate that BSA dilutions from 300 to 2000 μg/mL and rat plasma dilutions of 0.